if you look the disease progression (PD) was 0%... short time frame to predict anything but...
partial response was 36% ? means reduction in tumour size with abraxane combo ?
definitely great results but market will need time
Ann: Promising Clinical Data 1b ACCENT Trial in Pancreatic Cancer, page-8
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
-0.015(12.0%) |
Mkt cap ! $32.28M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 12.5¢ | 11.0¢ | $80.40K | 693.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 106873 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 55835 | 5 |
View Market Depth
| Last trade - 15.08pm 03/09/2024 (20 minute delay) ? |
| ATX (ASX) Chart |